Seroprevalence of Ebola virus infection in Bombali District, Sierra Leone


Submitted: 30 June 2017
Accepted: 1 July 2017
Published: 31 December 2017
Abstract Views: 1496
PDF: 708
HTML: 166
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Nadege Goumkwa Mafopa University of Dschang, Dschang, Cameroon; University of Makeni, Makeni, Sierra Leone; Holy Spirit Hospital, Maken, Sierra Leone.
  • Gianluca Russo Holy Spirit Hospital, Makeni, Sierra Leone; La Sapienza University of Rome, Rome, Italy.
  • Raoul Emeric Guetiya Wadoum University of Dschang, Dschang, Cameroon; University of Makeni, Makeni, Sierra Leone; Holy Spirit Hospital, Makeni, Sierra Leone; University of Rome Tor Vergata, Rome, Italy.
  • Emmanuel Iwerima African Union Support to Ebola Outbreak in West Africa, Ethiopia.
  • Vincent Batwala African Union Support to Ebola Outbreak in West Africa; Directorate of Research and Graduate Training, Mbarara University of Science and Technology, Uganda.
  • Marta Giovanetti Holy Spirit Hospital, Makeni, Sierra Leone; University of Rome “Tor Vergata”, Rome, Italy.
  • Antonella Minutolo Holy Spirit Hospital, Makeni, Sierra Leone; University of Rome “Tor Vergata”, Rome, Italy.
  • Patrick Turay Holy Spirit Hospital, Makeni, Sierra Leone.
  • Thomas B. Turay Partner Relief Development, Freetown, Sierra Leone.
  • Brima Kargbo Ministry of Health and Sanitation, Freetown, Sierra Leone.
  • Massimo Amicosante University of Rome “Tor Vergata”, Rome, Italy.
  • Mattei Maurizio University of Rome “Tor Vergata”, Rome, .
  • Carla Montesano University of Makeni, Makeni, Sierra Leone; Holy Spirit Hospital, Makeni, Sierra Leone; University of Rome “Tor Vergata”, Rome, Italy. http://orcid.org/0000-0002-9865-6619
  • Ebola Study Group
A serosurvey of anti-Ebola Zaire virus nucleoprotein IgG prevalence was carried out among Ebola virus disease survivors and their Community Contacts in Bombali District, Sierra Leone. Our data suggest that the specie of Ebola virus (Zaire) responsible of the 2013-2016 epidemic in West Africa may cause mild or asymptomatic infection in a proportion of cases, possibly due to an efficient immune response.

Mafopa, N. G., Russo, G., Guetiya Wadoum, R. E., Iwerima, E., Batwala, V., Giovanetti, M., Minutolo, A., Turay, P., Turay, T. B., Kargbo, B., Amicosante, M., Maurizio, M., Montesano, C., & Group, E. S. (2017). Seroprevalence of Ebola virus infection in Bombali District, Sierra Leone. Journal of Public Health in Africa, 8(2). https://doi.org/10.4081/jphia.2017.732

Downloads

Download data is not yet available.

Citations